Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Candida Auris and Covid-19: A Health Threatening Combination Publisher



Khojasteh S1, 2, 3 ; Jafarzdeh J4 ; Hosseini SA5 ; Haghani I1, 2 ; Turki H3 ; Gharehbolagh SA6 ; Abastabar M1, 2 ; Mahmoudi S7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  2. 2. Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
  3. 3. Molecular Medecine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  4. 4. Department of Medical Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran
  5. 5. Toxoplasmosis Research Center, Communicable Diseases, Institute, Mazandaran University of Medical Sciences, Mazandaran, Sari, Iran
  6. 6. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Source: Current Medical Mycology Published:2022


Abstract

Since its first emergence in December 2019, due to its fast distribution throughout the world, SARS-COV-2 become a global concern. With the extremely increased number of hospitalized patients, this situation provided a potential basis for the transmission of nosocomial infections. Candida auris is a multidrug-resistant pathogen with improved transmission dynamics and resistance traits. During the worldwide spread of COVID-19, cases or outbreaks of C. auris colonization or infection have been reported. Resistance to antifungal drugs has been observed in the causative agents of the majority of such cases. The focus in this review is on COVID-19-associated C. auris infections (case studies/outbreaks) and the pandemic's potential effect on antifungal drug resistance. Copyright© 2022, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center.
Other Related Docs
10. Candida Auris: A New Emerging Fungal Monster, Archives of Clinical Infectious Diseases (2019)
15. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
21. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)